Nomura Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Nomura Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.6M	Buy	43,678 +194	+0.4%	+$45.3K	0.02%	427
2026 Q1	$9.95M	Sell	43,484 -217	-0.5%	-$48.6K	0.03%	441
2025 Q4	$9.32M	Buy	43,701 +15,950	+57%	+$3.29M	0.02%	451
2025 Q3	$5.52M	Buy	27,751 +2,106	+8%	+$393K	0.01%	577
2025 Q2	$4.43M	Buy	25,645 +4,343	+20%	+$707K	0.01%	613
2025 Q1	$3.32M	Buy	21,302 +796	+4%	+$114K	0.01%	655
2024 Q4	$2.82M	Buy	20,506 +2,506	+14%	+$329K	0.01%	689
2024 Q3	$2.69M	Buy	18,000 +5,371	+43%	+$725K	0.01%	699
2024 Q2	$1.72M	Sell	12,629 -1,300	-9%	-$177K	0.01%	732
2024 Q1	$2.11M	Buy	13,929 +1,261	+10%	+$180K	0.01%	712
2023 Q4	$1.6M	Hold	12,668	–	–	0.01%	740
2023 Q3	$1.19M	Sell	12,668 -1,744	-12%	-$163K	0.01%	783
2023 Q2	$1.29M	Buy	14,412 +1,094	+8%	+$95.2K	0.01%	777
2023 Q1	$1.43M	Buy	13,318 +648	+5%	+$74.1K	0.01%	759
2022 Q4	$1.55M	Hold	12,670	–	–	0.01%	744
2022 Q3	$1.31M	Hold	12,670	–	–	0.01%	749
2022 Q2	$1.18M	Buy	12,670 +890	+8%	+$83.9K	0.01%	795
2022 Q1	$1.38M	Buy	11,780 +1,140	+11%	+$132K	0.01%	797
2021 Q4	$1.43M	Buy	10,640 +1,622	+18%	+$241K	0.01%	809
2021 Q3	$1.44M	Buy	9,018 +896	+11%	+$123K	0.01%	779
2021 Q2	$1.07M	Hold	8,122	–	–	0.01%	846
2021 Q1	$1.05M	Buy	+8,122	New	+$1.23M	0.01%	828

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Nomura Asset Management's ASND Position: Q2 2026 in Review

Nomura Asset Management increased its Ascendis Pharma A/S (ASND) stake by 0.45% in Q2 2026, buying an estimated $45.3K and bringing the position to 43,678 shares worth $11.6M. The position accounts for 0.02% of the portfolio, ranked #427.

Nomura Asset Management first reported a position in ASND in Q1 2021 and has held it in 22 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Nomura Asset Management held 43,678 shares of Ascendis Pharma A/S worth $11.6M as of Q2 2026.
Nomura Asset Management bought 194 Ascendis Pharma A/S shares in Q2 2026, an estimated $45.3K.
Ascendis Pharma A/S made up 0.02% of Nomura Asset Management's portfolio in Q2 2026, its #427 holding.
Nomura Asset Management first reported a position in Ascendis Pharma A/S in Q1 2021 and has held it in 22 quarters since.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.